abstract |
The present invention exhibits pharmacokinetic properties similar to those of commonly used T1 general extravascular agents (NSA), but is further characterized by high relaxivity, having one or more chelating backbone moieties. It relates to a new class of paramagnetic ionic contrast agents of formula (I) that are highly functionalized by the presence of polyhydroxylated chains. |